Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 22.22
(0.63%)
CNY 22.22
(0.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 379.57 Million CNY | -0.82% |
| 2022 | 372.7 Million CNY | 34.2% |
| 2021 | 278.35 Million CNY | 27.08% |
| 2020 | 220.73 Million CNY | 24.99% |
| 2019 | 175.66 Million CNY | 10.53% |
| 2018 | 158.28 Million CNY | 18.92% |
| 2017 | 131.16 Million CNY | 0.39% |
| 2016 | 202.54 Million CNY | 19.41% |
| 2015 | 98.53 Million CNY | 18.96% |
| 2014 | 87.54 Million CNY | 46.6% |
| 2013 | 60.97 Million CNY | 89.17% |
| 2012 | 33.67 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 32.76 Million CNY | -35.13% |
| 2024 Q1 | 79 Million CNY | -41.76% |
| 2024 Q3 | 21.43 Million CNY | -59.49% |
| 2023 Q4 | 113.03 Million CNY | 97.11% |
| 2023 Q3 | 57.34 Million CNY | 55.85% |
| 2023 FY | - CNY | -0.82% |
| 2023 Q1 | 70.85 Million CNY | -54.22% |
| 2023 Q2 | 36.79 Million CNY | -48.07% |
| 2022 Q4 | 154.76 Million CNY | 193.34% |
| 2022 Q2 | 23.92 Million CNY | -60.99% |
| 2022 Q1 | 61.34 Million CNY | -47.59% |
| 2022 FY | - CNY | 34.2% |
| 2022 Q3 | 52.76 Million CNY | 120.48% |
| 2021 Q3 | 35.55 Million CNY | 135.57% |
| 2021 Q4 | 117.03 Million CNY | 229.16% |
| 2021 Q1 | 44.56 Million CNY | -51.7% |
| 2021 Q2 | 15.09 Million CNY | -66.13% |
| 2021 FY | - CNY | 27.08% |
| 2020 Q2 | 9.19 Million CNY | -72.31% |
| 2020 Q3 | 31.43 Million CNY | 242.03% |
| 2020 FY | - CNY | 24.99% |
| 2020 Q4 | 92.28 Million CNY | 193.54% |
| 2020 Q1 | 33.19 Million CNY | -52.49% |
| 2019 Q3 | 10.5 Million CNY | 562.94% |
| 2019 FY | - CNY | 10.53% |
| 2019 Q4 | 69.85 Million CNY | 565.14% |
| 2019 Q2 | 1.58 Million CNY | -96.45% |
| 2019 Q1 | 44.58 Million CNY | -14.7% |
| 2018 Q1 | 34.34 Million CNY | -20.31% |
| 2018 FY | - CNY | 18.92% |
| 2018 Q4 | 52.26 Million CNY | 758.36% |
| 2018 Q3 | 6.08 Million CNY | -69.71% |
| 2018 Q2 | 20.09 Million CNY | -41.48% |
| 2017 FY | - CNY | 0.39% |
| 2017 Q1 | 33.4 Million CNY | -34.95% |
| 2017 Q2 | 30.87 Million CNY | -7.56% |
| 2017 Q3 | 7.43 Million CNY | -75.92% |
| 2017 Q4 | 43.09 Million CNY | 479.65% |
| 2016 Q1 | 30.64 Million CNY | 0.0% |
| 2016 Q4 | 51.35 Million CNY | 781.68% |
| 2016 FY | - CNY | 19.41% |
| 2016 Q3 | 5.82 Million CNY | -35.23% |
| 2016 Q2 | 8.99 Million CNY | -70.66% |
| 2015 FY | - CNY | 18.96% |
| 2014 FY | - CNY | 46.6% |
| 2013 FY | - CNY | 89.17% |
| 2012 FY | - CNY | 0.0% |